Monte Rosa Therapeutics, Inc. (GLUE)

14.01 -0.37 (-2.57%) USD  |  NASDAQ  |  Sep 04, 13:14
More

Monte Rosa Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 --
Date Value
December 31, 2024 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Nurix Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Capricor Therapeutics, Inc. --
Cue Biopharma, Inc. Upgrade